Home LiteratureArticle Details
PMID: 12435249 Published · ppublish English Letter Research Support, Non-U.S. Gov't Comment

Virologic outcomes of complex drug regimens for human immunodeficiency virus.

JAMA ·Vol. 288 ·No. 19 ·2002-11-20 ·Pages 2405-6; author reply 2406

Carr A

Abstract

暂无摘要

MeSH Terms
Alkynes Anti-HIV Agents/therapeutic use Antiretroviral Therapy, Highly Active Benzoxazines Cyclopropanes HIV Infections/drug therapy HIV Protease Inhibitors/therapeutic use Humans Oxazines/therapeutic use Reverse Transcriptase Inhibitors/therapeutic use Treatment Failure Viral Load
Chemicals
Alkynes Anti-HIV Agents Benzoxazines Cyclopropanes HIV Protease Inhibitors Oxazines Reverse Transcriptase Inhibitors efavirenz
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Carr Andrew
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
0098-7484
Published
2002-11-20
Pages
2405-6; author reply 2406
Language
English
Region
United States
NLM ID
7501160
Subset
IM
Corrections
CommentOn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com